Tata India Pharma & Heathcare Fund
The fund maintains a tight, conviction-driven thesis on pharma and healthcare with over half the portfolio in pharmaceuticals while strategically balancing with high-quality hospital chains. The top-heavy concentration—over half in ten names—reflects the manager's selective approach toward sector leaders rather than diversified exposure. The exit of Krishna Institute signals tactical rebalancing, possibly trimming smaller healthcare players to reinforce positions in proven operators like Sun Pharma and Abbott, suggesting confidence in large-cap defensive positioning within an expanding healthcare narrative.
Portfolio analysis · April 2026
NAV & Returns
| Plan | NAV | 1M | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|
| Direct Growth | ₹37.1788 | — | — | — | — |
| Regular Growth | ₹31.5869 | +7.65% | +6.81% | +23.87% | +14.13% |
Portfolio Metrics(latest month)
vs Category Peers
Highly DifferentiatedActive Share = ½Σ|wfund − wpeer|, computed using leave-one-out peer portfolio within SEBI category.
Similar Funds in Category
What Changed2026-03-31 → 2026-04-30
| Stock | Weight | |
|---|---|---|
| No new entries this month | ||
Full Holdings
| # | Holding | % to NAV |
|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LTD INE044A01036 | 9.87% |
| 2 | DIVI LABORATORIES LTD INE361B01024 | 5.92% |
| 3 | HEALTHCARE GLOBAL ENTERPRISES LTD INE075I01017 | 5.45% |
| 4 | ABBOTT INDIA LTD INE358A01014 | 5.37% |
| 5 | MAX HEALTHCARE INSTITUTE LTD INE027H01010 | 5.17% |
| 6 | CIPLA LTD INE059A01026 | 5.07% |
| 7 | RAINBOW CHILDRENS MEDICARE LTD INE961O01016 | 4.23% |
| 8 | APOLLO HOSPITALS ENTERPRISE LTD INE437A01024 | 4.06% |
| 9 | MANKIND PHARMA LTD INE634S01028 | 3.73% |
| 10 | DR REDDYS LABORATORIES LTD INE089A01031 | 3.73% |
| 11 | FORTIS HEALTHCARE LTD INE061F01013 | 3.55% |
| 12 | BAYER CROPSCIENCE LTD INE462A01022 | 3.34% |
| 13 | METROPOLIS HEALTHCARE LTD INE112L01020 | 3.07% |
| 14 | SYNGENE INTERNATIONAL LTD INE398R01022 | 2.94% |
| 15 | LUPIN LTD INE326A01037 | 2.94% |
| 16 | SAI LIFE SCIENCES LTD INE570L01029 | 2.63% |
| 17 | DR. LAL PATH LABS LTD INE600L01024 | 2.60% |
| 18 | ALKEM LABORATORIES LTD INE540L01014 | 2.49% |
| 19 | GLAXOSMITHKLINE PHARMACEUTICALS LTD INE159A01016 | 2.44% |
| 20 | NEULAND LABORATORIES LTD INE794A01010 | 2.41% |
Sector Allocation
Top 10 sectors by % to NAV. Excludes derivatives.
Frequently Asked Questions
How many stocks does Tata India Pharma & Heathcare Fund hold?
Tata India Pharma & Heathcare Fund holds 36 stocks as per the latest AMFI portfolio disclosure. The top 5 positions account for 31.78% of NAV.
What is the largest holding in Tata India Pharma & Heathcare Fund?
The largest position in Tata India Pharma & Heathcare Fund is SUN PHARMACEUTICAL INDUSTRIES LTD, accounting for 9.87% of NAV in the Pharmaceuticals & Biotechnology sector.
Is Tata India Pharma & Heathcare Fund a concentrated or diversified fund?
With a Gini coefficient of 0.381, Tata India Pharma & Heathcare Fund is well-diversified. The HHI concentration index is 41,673 bps, which is above the 2500 bps threshold for high concentration. The top 5 holdings together make up 31.78% of the portfolio.
What is the market cap allocation of Tata India Pharma & Heathcare Fund?
Based on SEBI's AMFI classification, Tata India Pharma & Heathcare Fund's equity portfolio is split as: Large Cap: 35.50%, Mid Cap: 24.08%, Small Cap: 40.02%. This reflects the fund's positioning within the market cap spectrum.
Which sectors does Tata India Pharma & Heathcare Fund invest in most?
Tata India Pharma & Heathcare Fund has the highest allocation to Pharmaceuticals & Biotechnology (58.72%), Healthcare Services (35.02%), Fertilizers & Agrochemicals (4.47%). The fund is invested across 5 sectors in total.
How actively managed is Tata India Pharma & Heathcare Fund compared to other Sectoral / Thematic funds?
Tata India Pharma & Heathcare Fund has an Active Share of 90.46%, classifying it as "Highly Differentiated" among 237 Sectoral / Thematic peers. This means the fund takes significantly different stock positions compared to its category peers.
What changed in Tata India Pharma & Heathcare Fund's portfolio in the latest month?
Between 2026-03-31 and 2026-04-30, Tata India Pharma & Heathcare Fund exited 1 stock (including KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD). Total holding count decreased from 40 to 39 stocks.